Integrating artificial intelligence into health care through data access: can the GDPR act as a beacon for policymakers?
Open accessThe DOI matches its Crossref record.
Abstract
The potential of artificial intelligence (AI) to promote better health care has taken the centre stage in modern debates on public health and health policy. Although AI is considered a contemporary innovation, it has been in development for more than a half century. AI research began in the 1950s, when Alan Turing raised the idea that machines could 1 day think as humans.1 Then came, in 1959, the first instance of ‘machine learning’ (ML), where computer scientists created a program capable of solving puzzles on its own.2 Now, AI promises to lead the next major technological revolution, similar in stature to electricity and the internet.3 In the field of health care, AI has already led to improvements, particularly in areas such as precision medicine, diagnosis tools, psychological support, and help for the elderly.4 AI technologies generally require large amounts of both personal and non-personal data to function. In health care specifically, AI technologies rely on personal information, including health-related data extracted from medical files or research participants’ results.5 Promoting AI and capturing its benefits for the health care system yet depend, in large part, on procuring a convenient access to this sensitive data.6 Ensuring that privacy protections are in place appears essential, especially with individuals showing substantial concerns about sharing their data in the medical and clinical context.7 Suggestions to implement public open databases to promote medical research have created some controversy in Europe and in North America. In the UK, citizens rejected the care.data project launched in 2014 due to privacy concerns. Although widely supported by health care professionals, the failure of the project was largely due to a lack of transparency about the envisioned uses of health information and the possibility to opt-out.8 In the United States (US), studies have shown that individuals’ willingness to participate in research involving their genetic data is affected by their concerns about their ability to protect their privacy in such context.9 Paradoxically, this lack of trust is counterbalanced by a growing popularity of direct-to-consumer genetic testing and health monitoring devices. These devices create massive flows of personal and health data, mostly to private companies. This ambivalent attitude of individuals toward data sharing is a major issue for any privacy and data protection regulation. Adequately assuring the right to privacy of citizens while facilitating access to personal data for research is probably one of the biggest challenges policymakers have to face in any country wishing to benefit from many opportunities of AI technologies in health care. Through the adoption of its new General Data Protection Regulation (GDPR),10 the European Union (EU) was the first to attempt to regulate AI through data protection legislation. This regulation paves the way for meaningful reforms in privacy legislation in the US and Canada. The GDPR covers all personal data processed by a data processor or controller established within the Union (art. 3.1, GDPR). It also extends to personal data of any data subject in the EU, no matter the establishment of the processor in two situations: whenever this processing is related the offering of goods or services to data subjects in the Union; and when related to the monitoring of their behavior within the Union (art. 2.2, GDPR). This means that many foreign companies’ activities may fall into the scope of the GDPR. Moreover, the extra-territorial reach of the new regulation puts pressure on Canada and the US to reform their own privacy legislation. Indeed, both systems likely fall short of some of the new requirements set by the EU regulation. If these laws are found to provide insufficient protection, the result could be a decrease in data flow from the EU to North America, due to the need to proceed via the adoption of additional contractual clauses.11 Such decrease would not only negatively affect research and development of AI technologies in both countries but would also interfere with any attempt at cooperation in the field.12 In this context, it appears all the more pressing to consider appropriate measures to consolidate privacy protection and promote stakeholders’ trust. After a brief overview of the contributions and promises of AI to the health sector, we will investigate the challenges to data and privacy protection brought about by developments in this field. This will lead us to identify key avenues for policy reform, in the US and Canada, which we contend could be inspired by the GDPR. There is no single definition for AI. According to the Canadian Standing Senate Committee on Social Affairs, Science and Technology, the expression refers to ‘the reproduction of human cognitive functions such as problem solving, reasoning, understanding, recognition, etc. by artificial means, specifically by computer’.13 In many health care systems, AI
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Ethical and regulatory challenges of AI technologies in healthcare: A narrative review
Mennella, C., Maniscalco, U., De Pietro, G., & Esposito, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26297 · Cited by 1,229
A Review of the Role of Artificial Intelligence in Healthcare
Al Kuwaiti, A., Nazer, K., Al-Reedy, A., Al-Shehri, S., Al-Muhanna, A., Subbarayalu, A. V., Al Muhanna, D., & Al-Muhanna, F. A. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13060951 · Cited by 915
Aung, Y. Y. M., Wong, D. C. S., & Ting, D. S. W. (2021) · British Medical Bulletin · doi:10.1093/bmb/ldab016 · Cited by 511
“34 Therefore, these regulations importantly must be coupled with improved data security practices, in order to not hinder developments in the field.”
Backgroundde Hond, A. A. H., Leeuwenberg, A. M., Hooft, L., Kant, I. M. J., Nijman, S. W. J., van Os, H. J. A., Aardoom, J. J., Debray, T. P. A., Schuit, E., van Smeden, M., et al. (2022) · npj Digital Medicine · doi:10.1038/s41746-021-00549-7 · Cited by 499
Singh, S., Kumar, R., Payra, S., & Singh, S. K. (2023) · Cureus · doi:10.7759/cureus.44359 · Cited by 154
Metadata
- Authors
- Forcier, M. B., Gallois, H., Mullan, S., & Joly, Y.
- Venue
- Journal of Law and the Biosciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-09-16
- Volume
- 6
- Issue
- 1
- Pages
- 317-335
- ISSN
- 2053-9711 (ISSN-L)
- OpenAlex
- W2973683152
- Cited by
- 135
- References
- 0
- FWCI
- 73.09
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Integrating artificial intelligence into health care through data access: can the GDPR act as a beacon for policymakers? https://app.cochat.ai/papers/10.1093/jlb/lsz013
- The paper
- Forcier, M. B., Gallois, H., Mullan, S., & Joly, Y. (2019). Integrating artificial intelligence into health care through data access: can the GDPR act as a beacon for policymakers? Journal of Law and the Biosciences. https://doi.org/10.1093/jlb/lsz013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.